Ceyda Acilan

7PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 17, 2026
Nicotinamide N-methyltransferase as a therapeutic target in taxane-resistant castration-resistant prostate cancer.

|Jan 07, 2026
Identification of epigenetic monotherapy candidates in taxane-resistant CRPC.

Buse Cevatemre, İpek Bulut, Ezgi Karyemez

|Aug 08, 2025
Epidrug screening identifies type I PRMT inhibitors as modulators of lysosomal exocytosis and drug sensitivity in cancers.

Baris Sergi, Neslihan Yuksel-Catal, Selahattin Can Ozcan

|Jul 18, 2025
Butyrylcholinesterase (BChE) downregulation in taxane resistance: implications for prostate cancer.

Buse Cevatemre, Arda Işiklar, İpek Bulut

|Jun 29, 2025
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancer.

Ozlem Yedier-Bayram, Ahmet Cingöz, Ebru Yilmaz

|Feb 12, 2024
Exploiting epigenetic targets to overcome taxane resistance in prostate cancer.

Buse Cevatemre, Ipek Bulut, Beyza Dedeoglu

Pageof 2

Frequent Collaborators

5 joint publications

Ceyda Acilan

4 joint publications

Hamzah Syed

3 joint publications

Ipek Bulut

3 joint publications

Tugba Bagci-Onder